ACTIVE

Leo Pharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

615,4 k €

-10.1% YoY

Revenue

32,1 M €

-5.4% YoY

Equity

9,9 M €

+6.6% YoY

Workforce

21,7 ETP

-13.2% YoY

What does Leo Pharma do?

Leo Pharma is a Public limited company incorporated in 1967. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Lier. It employs on average 21,7 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0404.780.604

Incorporation

01/04/1967

Legal form

Public limited company

Registered office

Duwijckstraat 17
2500 Lier · FlandreSee on map

Contributed capital

644 523,10 €

Latest accounts

31/12/2025

Average workforce

21,7 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (3)

Contacts

4 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2009		2008		2007		2006
Income statement
Revenue	32,1 M €	-5.4%	33,9 M €	+2.5%	33,1 M €	+22.7%	27 M €	-0.7%	27,2 M €	+0.4%	27 M €	-3.2%	27,9 M €	+3.5%	27 M €	+2.4%	26,3 M €	-1.2%	26,7 M €	+3.2%	25,8 M €	-7.5%	27,9 M €	+13.5%	24,6 M €	+25.8%	19,6 M €	+3.6%	18,9 M €	+4.6%	18,1 M €	+10.5%	16,4 M €
EBITDA	815,1 k €	-6.0%	867 k €	-13.9%	1 M €	+644%	135,3 k €	-73.5%	509,5 k €	-71.8%	1,8 M €	+59.1%	1,1 M €	+29.7%	876,2 k €	+46.2%	599,2 k €	-20.9%	757,1 k €	+35.4%	559 k €	-69.7%	1,8 M €	+42.8%	1,3 M €	-60.0%	3,2 M €	+5.0%	3,1 M €	+4.7%	2,9 M €	+7.0%	2,7 M €
Operating result	798,7 k €	-5.6%	845,9 k €	-13.2%	974 k €	+1047%	84,9 k €	-87.2%	664,6 k €	-61.5%	1,7 M €	+75.5%	983,2 k €	+21.4%	810,2 k €	+48.3%	546,5 k €	-22.5%	704,7 k €	+46.7%	480,3 k €	-72.5%	1,7 M €	+46.5%	1,2 M €	-62.9%	3,2 M €	+5.0%	3,1 M €	+3.9%	2,9 M €	+8.5%	2,7 M €
Net result	615,4 k €	-10.1%	684,3 k €	-13.8%	793,4 k €	+573%	-167,6 k €	-141%	413,2 k €	-64.5%	1,2 M €	+73.3%	672 k €	+49.2%	450,5 k €	+9.1%	413 k €	-29.2%	583,6 k €	+24.2%	469,8 k €	-60.0%	1,2 M €	+38.9%	845,1 k €	-62.6%	2,3 M €	-20.0%	2,8 M €	-7.6%	3,1 M €	+50.9%	2 M €
Balance sheet
Equity	9,9 M €	+6.6%	9,3 M €	+7.9%	8,6 M €	+10.1%	7,8 M €	-2.1%	8 M €	-56.0%	18,2 M €	+6.8%	17 M €	+4.1%	16,4 M €	+2.8%	15,9 M €	+2.7%	15,5 M €	+3.9%	14,9 M €	+3.2%	14,5 M €	+8.8%	13,3 M €	+13.9%	11,7 M €	+24.0%	9,4 M €	+43.0%	6,6 M €	+86.9%	3,5 M €
Total assets	15,1 M €	+23.9%	12,1 M €	-30.5%	17,5 M €	-8.4%	19,1 M €	-8.1%	20,7 M €	-20.2%	26 M €	-8.5%	28,4 M €	+7.1%	26,5 M €	+6.7%	24,8 M €	+5.8%	23,5 M €	+7.3%	21,9 M €	-13.1%	25,2 M €	+19.8%	21 M €	+13.1%	18,6 M €	+12.1%	16,6 M €	+24.1%	13,4 M €	+46.5%	9,1 M €
Cash	–		–		–		0 €	-100%	2,9 k €		–		764,6 k €	+39.5%	548,1 k €	-43.0%	960,9 k €	+37.6%	698,2 k €	-42.1%	1,2 M €	-66.1%	3,6 M €	+9011%	39 k €	+476%	6,8 k €	-97.8%	308,5 k €	-89.6%	3 M €	+148694%	2 k €
Debts	5,1 M €	+85.8%	2,7 M €	-69.0%	8,8 M €	-21.3%	11,2 M €	-11.8%	12,7 M €	+96.3%	6,4 M €	-34.6%	9,9 M €	+11.0%	8,9 M €	+7.0%	8,3 M €	+12.7%	7,4 M €	+10.8%	6,6 M €	-34.5%	10,1 M €	+43.7%	7,1 M €	+4.8%	6,7 M €	+0.6%	6,7 M €	+4.8%	6,4 M €	+32.5%	4,8 M €
Other
Workforce	21,7 ETP	-13.2%	25,0 ETP	-6.7%	26,8 ETP	-18.3%	32,8 ETP	-0.9%	33,1 ETP	+7.1%	30,9 ETP	+12.8%	27,4 ETP	-1.8%	27,9 ETP	+0.4%	27,8 ETP	-9.7%	30,8 ETP	-5.2%	32,5 ETP	-19.8%	40,5 ETP	-5.4%	42,8 ETP	+67.8%	25,5 ETP	-6.6%	27,3 ETP	-22.4%	35,2 ETP	+13.5%	31,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 38 ended

Active mandates

Dilay Kücükkose

Director · since 27 janvier 2025 · until 02 juin 2031

Active

Anders KRUGER

Director · since 31 janvier 2024 · until 27 janvier 2025

Active

Hilda De Swaef

Director · since 31 mars 2022 · until 31 mai 2028

Active

Ended mandates

Anders Kruger

Director · since 31 janvier 2024 · until 31 mai 2029

Ended

Jannie Holm

Director · since 31 mars 2022 · until 31 janvier 2024

Ended

Jannie Holm

Director · since 31 mars 2022 · until 31 mai 2028

Ended

Michael Grue

Director · since 06 juillet 2021 · until 31 mars 2022

Ended

At this address

Other companies at this address

Company	CBE no.
3D-PDG● Active	0707.567.092
Alro Food● Active	0683.564.443
Ando PoolCo● Active	0802.452.888
ANI HOLDING BELGIE● Active	0480.206.220
AUXIFINA● Active	0464.375.028
AVINEON● Active	0832.880.305
BAUW● Bankrupt	0454.316.524
BIZZAPPS● Active	0803.123.871
BLICKLE● Active	0416.649.543
CONTENTSERV BENELUX● Active	0845.056.674
Creafin● Active	0455.731.338
DATASOFT SERVICES● Active	0464.659.593
DE KARWEIMAN● Bankrupt	0461.859.263
DELTA BELGIUM● Active	0434.193.972
DELTA - EM● Active	0463.485.596
DESCARTES SYSTEMS (BELGIUM)● Active	0467.369.853
DOUBLE SEVEN● Active	0893.793.236
DUBRICK● Active	0694.579.782
DUHOLD● Active	0476.319.290
DVB & H Accountants● Active	1027.989.766

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	06/05/2026	23/06/2025	21/05/2024	05/06/2023	28/07/2022	23/07/2021
General meeting	30/04/2026	28/05/2025	03/05/2024	31/05/2023	07/07/2022	15/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/04/2026	06/05/2026	Dutch	PDF
Full model	31/12/2024	28/05/2025	23/06/2025	Dutch	PDF
Full model	31/12/2023	03/05/2024	21/05/2024	Dutch	PDF
Full model	31/12/2022	31/05/2023	05/06/2023	Dutch	PDF
Full model	31/12/2021	07/07/2022	28/07/2022	Dutch	PDF
Full model	31/12/2020	15/07/2021	23/07/2021	Dutch	PDF
Full model	31/12/2019	30/06/2020	13/07/2020	Dutch	PDF
Full model	31/12/2018	25/11/2019	29/11/2019	Dutch	PDF
Full model	31/12/2017	20/09/2018	28/09/2018	Dutch	PDF
Full model	31/12/2016	07/04/2017	27/04/2017	Dutch	PDF
Full model	31/12/2015	01/04/2016	19/04/2016	Dutch	PDF
Full model	31/12/2014	03/04/2015	06/05/2015	Dutch	PDF
Full model	31/12/2013	11/04/2014	08/05/2014	Dutch	PDF
Full model	31/12/2012	11/04/2013	22/04/2013	Dutch	PDF
Full model	31/12/2011	26/04/2012	22/05/2012	Dutch	PDF
Full model	31/12/2010	21/03/2011	24/08/2011	Dutch	PDF
Full model	31/12/2009	31/08/2010	31/08/2010	Dutch	PDF
Full model	31/12/2008	27/03/2009	26/06/2009	Dutch	PDF
Full model	31/12/2007	04/03/2008	27/08/2008	Dutch	PDF
Full model	31/12/2006	06/03/2007	26/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 38 ended

Active mandates

Dilay Kücükkose

Director · since 27 janvier 2025 · until 02 juin 2031

Active

Anders KRUGER

Director · since 31 janvier 2024 · until 27 janvier 2025

Active

Hilda De Swaef

Director · since 31 mars 2022 · until 31 mai 2028

Active

Ended mandates

Anders Kruger

Director · since 31 janvier 2024 · until 31 mai 2029

Ended

Jannie Holm

Director · since 31 mars 2022 · until 31 janvier 2024

Ended

Jannie Holm

Director · since 31 mars 2022 · until 31 mai 2028

Ended

Michael Grue

Director · since 06 juillet 2021 · until 31 mars 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates09/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Other15/04/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates11/02/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/02/2024
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates28/06/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/09/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/08/2022
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025615,4 k €↓
2024
Annual accounts 2024684,3 k €↓
2023
Annual accounts 2023793,4 k €↑
2022
Annual accounts 2022-167,6 k €↓
2021
Annual accounts 2021413,2 k €↓
2018
Annual accounts 20181,2 M €↑
2017
Annual accounts 2017672 k €↑
2016
Annual accounts 2016450,5 k €↑
2015
Annual accounts 2015413 k €↓
2014
Annual accounts 2014583,6 k €↑
2013
Annual accounts 2013469,8 k €↓
2012
Annual accounts 20121,2 M €↑
2011
Annual accounts 2011845,1 k €↓
2009
Annual accounts 20092,3 M €↓
2008
Annual accounts 20082,8 M €↓
2007
Annual accounts 20073,1 M €↑
2006
Annual accounts 20062 M €
01/04/1967
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Leo Pharma

Overview

What does Leo Pharma do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline